<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Faecal 3-hydroxy <z:chebi fb="1" ids="3098">bile acids</z:chebi> were assayed enzymatically in patients with <z:mp ids='MP_0002038'>carcinoma</z:mp>, or at increased risk of developing <z:mp ids='MP_0002038'>carcinoma</z:mp> of the large bowel </plain></SENT>
<SENT sid="1" pm="."><plain>No rise in <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentration was demonstrated in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, previously resected <z:mpath ids='MPATH_270'>adenoma</z:mpath>, or resected <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:mp ids='MP_0002038'>carcinoma</z:mp>, before treatment, had faecal <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentrations similar to control values, and surgery did not affect the mean level </plain></SENT>
<SENT sid="3" pm="."><plain>These findings cast doubt on the importance of the 3-hydroxy <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentration in the faeces in the pathogenesis of <z:e sem="disease" ids="C0009402" disease_type="Neoplastic Process" abbrv="CRC">large bowel cancer</z:e> </plain></SENT>
</text></document>